NO305397B1 - Kinuklidinesterprosess og mellomprodukter ved fremstilling av kinuklidinestere og farmas°ytiske sammensetninger inneholdende dem - Google Patents

Kinuklidinesterprosess og mellomprodukter ved fremstilling av kinuklidinestere og farmas°ytiske sammensetninger inneholdende dem

Info

Publication number
NO305397B1
NO305397B1 NO940905A NO940905A NO305397B1 NO 305397 B1 NO305397 B1 NO 305397B1 NO 940905 A NO940905 A NO 940905A NO 940905 A NO940905 A NO 940905A NO 305397 B1 NO305397 B1 NO 305397B1
Authority
NO
Norway
Prior art keywords
pct
kinuclidine
intermediates
preparation
alkyl
Prior art date
Application number
NO940905A
Other languages
English (en)
Norwegian (no)
Other versions
NO940905D0 (no
NO940905L (no
Inventor
Peter Edward Cross
Alan Stobie
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO940905D0 publication Critical patent/NO940905D0/no
Publication of NO940905L publication Critical patent/NO940905L/no
Publication of NO305397B1 publication Critical patent/NO305397B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO940905A 1991-09-14 1994-03-14 Kinuklidinesterprosess og mellomprodukter ved fremstilling av kinuklidinestere og farmas°ytiske sammensetninger inneholdende dem NO305397B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919119705A GB9119705D0 (en) 1991-09-14 1991-09-14 Therapeutic compounds
PCT/EP1992/002067 WO1993006098A1 (en) 1991-09-14 1992-09-03 Quinuclidine esters process and intermediate for their preparation and pharmaceutical compositions containing them

Publications (3)

Publication Number Publication Date
NO940905D0 NO940905D0 (no) 1994-03-14
NO940905L NO940905L (no) 1994-03-14
NO305397B1 true NO305397B1 (no) 1999-05-25

Family

ID=10701448

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940905A NO305397B1 (no) 1991-09-14 1994-03-14 Kinuklidinesterprosess og mellomprodukter ved fremstilling av kinuklidinestere og farmas°ytiske sammensetninger inneholdende dem

Country Status (31)

Country Link
US (1) US5543419A (de)
EP (1) EP0603229B1 (de)
JP (2) JP2672030B2 (de)
KR (1) KR0135784B1 (de)
CN (1) CN1037269C (de)
AT (1) ATE167187T1 (de)
AU (1) AU659487B2 (de)
BR (1) BR9206499A (de)
CA (1) CA2116356C (de)
CZ (1) CZ281752B6 (de)
DE (1) DE69225897T2 (de)
DK (1) DK0603229T3 (de)
EG (1) EG20072A (de)
ES (1) ES2116343T3 (de)
FI (1) FI114707B (de)
GB (1) GB9119705D0 (de)
GR (1) GR3027667T3 (de)
HU (1) HU220594B1 (de)
IL (1) IL103078A (de)
MX (1) MX9205221A (de)
MY (1) MY108602A (de)
NO (1) NO305397B1 (de)
NZ (1) NZ244324A (de)
PL (1) PL170627B1 (de)
PT (1) PT100863B (de)
RU (1) RU2117669C1 (de)
SG (1) SG50414A1 (de)
TW (1) TW251285B (de)
UA (1) UA42686C2 (de)
WO (1) WO1993006098A1 (de)
ZA (1) ZA926939B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT785198E (pt) * 1996-01-19 2000-11-30 Lonza Ag Processo para a producao de 3-quinuclidinol opticamente activo.
CZ54498A3 (cs) * 1997-03-07 1998-11-11 Lonza Ag Katalyzátorová směs na bázi amorfního částečně dehydratovaného hydroxidu zirkoničitého a způsob její výroby a použití
DE69833665T2 (de) * 1997-08-08 2006-11-09 Duke University Zusammensetzungen zur vereinfachung von chirurgischen verfahren
US6711436B1 (en) 1997-08-08 2004-03-23 Duke University Compositions, apparatus and methods for facilitating surgical procedures
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
HUP0303529A3 (en) * 2000-12-22 2008-03-28 Almirall Ag New quinuclidine carbamate derivatives, process for their preparation and pharmaceutical compositions containing them and their use
CN1250545C (zh) 2000-12-28 2006-04-12 阿尔米雷尔普罗迪斯制药有限公司 新的奎宁环衍生物类及含有这类衍生物的药物组合物
GB0424284D0 (en) * 2004-11-02 2004-12-01 Novartis Ag Organic compounds
DE102004057995A1 (de) * 2004-12-01 2006-06-08 Wacker Chemie Ag Verfahren zur Herstellung von α,α-Dialkyl-α-Hydroxymethyl-Carbonsäurederivaten
ES2298049B1 (es) * 2006-07-21 2009-10-20 Laboratorios Almirall S.A. Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
EP2114972A2 (de) * 2006-12-13 2009-11-11 Gilead Sciences, Inc. Monophosphate als gemeinsame prodrugs für muskarinrezeptorantagonisten und beta-agonisten für die behandlung von copd und chronischer bronchitis
EP2100599A1 (de) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
EP2100598A1 (de) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
EP2510928A1 (de) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium zur Verbesserung der Schlafqualität bei atemwegserkrankten Patienten

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843074A (en) * 1988-05-17 1989-06-27 Marion Laboratories, Inc. 1-azabicyclo[2.2.2]octan-3-yl 2-aryl-3-azacyclo-2-hydroxypropionates and their quaternary salts
GB8923590D0 (en) * 1989-10-19 1989-12-06 Pfizer Ltd Antimuscarinic bronchodilators

Also Published As

Publication number Publication date
JPH06510991A (ja) 1994-12-08
FI114707B (fi) 2004-12-15
EG20072A (en) 1999-06-30
CA2116356C (en) 1998-03-31
CZ281752B6 (cs) 1997-01-15
EP0603229B1 (de) 1998-06-10
JPH09315970A (ja) 1997-12-09
KR0135784B1 (ko) 1998-04-23
NZ244324A (en) 1993-12-23
MX9205221A (es) 1993-03-01
GR3027667T3 (en) 1998-11-30
JP2672030B2 (ja) 1997-11-05
ATE167187T1 (de) 1998-06-15
HU220594B1 (hu) 2002-03-28
JP2955533B2 (ja) 1999-10-04
FI941170A0 (fi) 1994-03-11
WO1993006098A1 (en) 1993-04-01
BR9206499A (pt) 1995-11-21
MY108602A (en) 1996-10-31
CN1070911A (zh) 1993-04-14
IL103078A0 (en) 1993-02-21
UA42686C2 (uk) 2001-11-15
DE69225897T2 (de) 1998-10-15
CN1037269C (zh) 1998-02-04
NO940905D0 (no) 1994-03-14
IL103078A (en) 1996-07-23
GB9119705D0 (en) 1991-10-30
AU659487B2 (en) 1995-05-18
DK0603229T3 (da) 1998-10-12
AU2482392A (en) 1993-04-27
PT100863A (pt) 1993-10-29
EP0603229A1 (de) 1994-06-29
ZA926939B (en) 1994-03-11
ES2116343T3 (es) 1998-07-16
CA2116356A1 (en) 1993-04-01
HU9400729D0 (en) 1994-06-28
NO940905L (no) 1994-03-14
US5543419A (en) 1996-08-06
RU2117669C1 (ru) 1998-08-20
CZ395392A3 (en) 1994-07-13
PL170627B1 (en) 1997-01-31
DE69225897D1 (de) 1998-07-16
PT100863B (pt) 1999-07-30
HUT66772A (en) 1994-12-28
FI941170L (fi) 1994-03-11
SG50414A1 (en) 1998-07-20
TW251285B (de) 1995-07-11

Similar Documents

Publication Publication Date Title
NO940905L (no) Kinuklidinesterprosess og mellomprodukter ved fremstilling av kinuklidinestere og farmasöytiske sammensetninger inneholdende dem
HU906495D0 (en) Process for producing compounds and pharmaceutical preparatives of anti-muscarinic effect
AU550774B2 (en) 1-aryl-2-aminomethyl cyclopropane carboxylates
AU659279B2 (en) Pyrimidine derivatives
DE69231445D1 (de) Triazole enthaltende antifungizide mittel
CS243498B2 (en) Method of new beta-lactams production
KR960704536A (ko) 안트라사이클리논 유도체 및 유전분증에서의 이의 용도(Anthracyclinone derivatives and their use in amyloidosis)
TW427975B (en) Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
RU94019411A (ru) Эфиры хинук лидина, промежуточные соединения для их синтеза, фармацевтическая композиция и способ лечения
FI102679B1 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten sertindoli-prodrugjohdannaisten valmistamiseksi
MX9700765A (es) Derivados de ariloxi y ariltiopropanolamina utiles como agonistas de beta 3-adrenorreceptor y antagonistas de beta 1 y beta 2-adrenorreceptores y composiciones farmaceuticas de los mismos.
EP0712398A1 (de) Benzopyrane und diese enthaltende pharmazeutische zusammenstellungen
BR9307091A (pt) Acido benzenoalcanóicos para doenças cardiovasculares
CA2384018A1 (en) Muscarinic antagonists
YU9199A (en) Naphtyl compounds, intermediates, compositions, and metods for use
EP0347902A3 (de) Pyrrolecarbonsäure-Derivate
NO933241L (no) Aminosyrer nyttige ved terapi av osteoartikulaere paavirkninger
AU703163B2 (en) Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions
HUP0100407A2 (hu) Eljárás kinolin-karbamoil- és kinolin-tiokarbamoil-származékok előállítására és az eljárás intermedierjei
SE8401064L (sv) Nya isoxazoler och forfarande for framstellning derav
ES8504699A1 (es) Procedimiento para la obtencion de nuevos acidos aceticos heterociclicos